{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:29:41Z","timestamp":1791930581616,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010127","name":"J\u00fcrgen Manchot Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["726368"],"award-info":[{"award-number":["726368"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bpc.2026.107642","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:17:43Z","timestamp":1777519063000},"page":"107642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An islet amyloid polypeptide oligomer model inhibits fibril formation"],"prefix":"10.1016","volume":"335","author":[{"given":"Anne","family":"Pfitzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina M.","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Hasecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Gremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2026.107642_bb0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"\u03b2-Cell deficit and increased \u03b2-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2026.107642_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/diabetes.48.2.241","article-title":"Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes","volume":"48","author":"Kahn","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2026.107642_bb0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/13506129409148624","article-title":"Amyloid and polypeptide hormones: what is their interrelationship?","volume":"1","author":"Westermark","year":"1994","journal-title":"Amyloid"},{"key":"10.1016\/j.bpc.2026.107642_bb0020","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1073\/pnas.93.14.7283","article-title":"Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide","volume":"93","author":"Janson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpc.2026.107642_bb0025","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1038\/s41598-019-54570-8","article-title":"Unpacking the aggregation-oligomerization-fibrillization process of naturally-occurring hIAPP amyloid oligomers isolated directly from sera of children with obesity or diabetes mellitus","volume":"9","author":"Altamirano-Bustamante","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107642_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237667","article-title":"Protein-conformational diseases in childhood: naturally-occurring hIAPP amyloid-oligomers and early \u03b2-cell damage in obesity and diabetes","volume":"15","author":"Altamirano-Bustamante","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2026.107642_bb0035","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1039\/C8CC03097A","article-title":"hIAPP forms toxic oligomers in plasma","volume":"54","author":"Camargo","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bpc.2026.107642_bb0040","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41467-018-03651-9","article-title":"Conformational switching within dynamic oligomers underpins toxic gain-of-function by diabetes-associated amyloid","volume":"9","author":"Birol","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bpc.2026.107642_bb0045","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diab.39.5.634","article-title":"Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells","volume":"39","author":"Kahn","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2026.107642_bb0050","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc07-2446","article-title":"Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide","volume":"31","author":"Woerle","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2026.107642_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0014-5793(89)81527-3","article-title":"Secretion of islet amyloid polypeptide in response to glucose","volume":"259","author":"Kanatsuka","year":"1989","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bpc.2026.107642_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-8993(00)03070-5","article-title":"Effects of long-term infusion of anorexic concentrations of islet amyloid polypeptide on neurotransmitters and neuropeptides in rat brain","volume":"887","author":"Arnelo","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bpc.2026.107642_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-0115(02)00252-5","article-title":"Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets","volume":"111","author":"\u00c5kesson","year":"2003","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bpc.2026.107642_bb0070","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1126\/science.aao2825","article-title":"Fibril structure of amyloid-\u03b2 (1\u201342) by cryo\u2013electron microscopy","volume":"358","author":"Gremer","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bpc.2026.107642_bb0075","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.36402","article-title":"Cryo-EM structure of alpha-synuclein fibrils","volume":"7","author":"Guerrero-Ferreira","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.bpc.2026.107642_bb0080","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41594-020-0442-4","article-title":"Cryo-EM structure of islet amyloid polypeptide fibrils reveals similarities with amyloid-\u03b2 fibrils","volume":"27","author":"Roeder","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1084\/jem.5.4.397","article-title":"On the relation of chronic interstitial pancreatitis to the islands of Langerhans and to diabetes melutus","volume":"5","author":"Opie","year":"1901","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bpc.2026.107642_bb0090","first-page":"968","article-title":"Zur Kenntnis der feineren Ver\u00e4nderungen des Pankreas bei Diabetes mellitus","volume":"14","author":"Weichselbaum","year":"1901","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.bpc.2026.107642_bb0095","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0006-291X(86)90708-4","article-title":"A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas","volume":"140","author":"Westermark","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bpc.2026.107642_bb0100","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpc.2026.107642_bb0105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.12977","article-title":"Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics","volume":"5","author":"Abedini","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.bpc.2026.107642_bb0110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/er.2007-0037","article-title":"Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis","volume":"29","author":"Haataja","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bpc.2026.107642_bb0115","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/diabetes.52.9.2304","article-title":"Increased beta-cell apoptosis prevents adaptive increase in beta-cell mass in mouse model of type 2 diabetes: evidence for role of islet amyloid formation rather than direct action of amyloid","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2026.107642_bb0120","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2353\/ajpath.2010.090532","article-title":"Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway","volume":"176","author":"Gurlo","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2026.107642_bb0125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2337\/db06-1579","article-title":"Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP\u2013induced \u03b2-cell apoptosis in h-IAPP transgenic mice","volume":"56","author":"Lin","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2026.107642_bb0130","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","article-title":"Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1\u03b2 in type 2 diabetes","volume":"11","author":"Masters","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bpc.2026.107642_bb0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bpc.2026.107642_bb0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bpc.2026.107642_bb0145","doi-asserted-by":"crossref","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","article-title":"Inhibition of human IAPP fibril formation does not prevent \u03b2-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP","volume":"291","author":"Meier","year":"2006","journal-title":"Am. J. Physiol.-Endocrinol. Metabol."},{"key":"10.1016\/j.bpc.2026.107642_bb0150","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1038\/srep04267","article-title":"Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies","volume":"4","author":"Bram","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107642_bb0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2026.107642_bb0160","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1074\/jbc.275.19.14077","article-title":"Alzheimer\u2019s beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line","volume":"275","author":"Kawahara","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106505","article-title":"Visualizing and trapping transient oligomers in amyloid assembly pathways","volume":"268","author":"Cawood","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0170","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1007\/s00216-020-02560-5","article-title":"Evidence for different in vitro oligomerization behaviors of synthetic hIAPP obtained from different sources","volume":"412","author":"Berardet","year":"2020","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0175","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A\u03b2 oligomers \u2013 a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bpc.2026.107642_bb0180","doi-asserted-by":"crossref","first-page":"S567","DOI":"10.3233\/JAD-179941","article-title":"The amyloid-\u03b2 oligomer hypothesis: beginning of the third decade","volume":"64","author":"Cline","year":"2018","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.bpc.2026.107642_bb0185","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1039\/C9SC06501F","article-title":"Identification of on- and off-pathway oligomers in amyloid fibril formation","volume":"11","author":"Dear","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bpc.2026.107642_bb0190","doi-asserted-by":"crossref","first-page":"1120416","DOI":"10.3389\/fmolb.2023.1120416","article-title":"Amyloid oligomers as on-pathway precursors or off-pathway competitors of fibrils","volume":"10","author":"Muschol","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bpc.2026.107642_bb0195","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-010-1671-6","article-title":"Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?","volume":"53","author":"Zraika","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2026.107642_bb0200","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41580-018-0060-8","article-title":"A new era for understanding amyloid structures and disease","volume":"19","author":"Iadanza","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nn1372","article-title":"Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function","volume":"8","author":"Cleary","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bpc.2026.107642_bb0210","doi-asserted-by":"crossref","first-page":"46363","DOI":"10.1074\/jbc.C400260200","article-title":"Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases","volume":"279","author":"Kayed","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0215","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1471-4159.2007.04809.x","article-title":"Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration","volume":"103","author":"Vieira","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bpc.2026.107642_bb0220","doi-asserted-by":"crossref","first-page":"14745","DOI":"10.1073\/pnas.0905127106","article-title":"Structure\u2013neurotoxicity relationships of amyloid \u03b2-protein oligomers","volume":"106","author":"Ono","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bpc.2026.107642_bb0225","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1039\/C8SC01479E","article-title":"Origin of metastable oligomers and their effects on amyloid fibril self-assembly","volume":"9","author":"Hasecke","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bpc.2026.107642_bb0230","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41467-021-24900-4","article-title":"Endo-lysosomal a\u03b2 concentration and pH trigger formation of a\u03b2 oligomers that potently induce tau missorting","volume":"12","author":"Sch\u00fctzmann","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bpc.2026.107642_bb0235","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1002\/ange.202010098","article-title":"Protofibril\u2013fibril interactions inhibit amyloid fibril assembly by obstructing secondary nucleation","volume":"133","author":"Hasecke","year":"2021","journal-title":"Angew. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0240","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1039\/D1SC06337E","article-title":"Anatomy and formation mechanisms of early amyloid-\u03b2 oligomers with lateral branching: graph network analysis on large-scale simulations","volume":"13","author":"Yuan","year":"2022","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bpc.2026.107642_bb0245","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1002\/anie.200904902","article-title":"Identification of hot regions of the a\u03b2\u2013IAPP interaction interface as high-affinity binding sites in both cross-and self-association","volume":"49","author":"Andreetto","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bpc.2026.107642_bb0250","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1074\/jbc.M311300200","article-title":"Seeding specificity in amyloid growth induced by heterologous fibrils","volume":"279","author":"O\u2019Nuallain","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0255","doi-asserted-by":"crossref","first-page":"19285","DOI":"10.1073\/pnas.1314481110","article-title":"Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient beta-sheet","volume":"110","author":"Buchanan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpc.2026.107642_bb0260","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1021\/ja1081537","article-title":"The amyloid formation mechanism in human IAPP: dimers have beta-strand monomer-monomer interfaces","volume":"133","author":"Dupuis","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bpc.2026.107642_bb0265","doi-asserted-by":"crossref","first-page":"33474","DOI":"10.1038\/srep33474","article-title":"\u03b2-Hairpin of islet amyloid polypeptide bound to an aggregation inhibitor","volume":"6","author":"Mirecka","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107642_bb0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/protein\/gzp036","article-title":"A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides","volume":"22","author":"Abedini","year":"2009","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.bpc.2026.107642_bb0275","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pro.145","article-title":"Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process","volume":"18","author":"Wiltzius","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.bpc.2026.107642_bb0280","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2528103123","article-title":"A structural model of toxic amyloid oligomers involved in type 2 diabetes","volume":"123","author":"Shivani","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpc.2026.107642_bb0285","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/s41594-020-0496-3","article-title":"Fibril structures of diabetes-related amylin variants reveal a basis for surface-templated assembly","volume":"27","author":"Gallardo","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0290","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41594-020-0435-3","article-title":"Cryo-EM structure and inhibitor design of human IAPP (amylin) fibrils","volume":"27","author":"Cao","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0295","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41594-021-00646-x","article-title":"Cryo-EM structures of hIAPP fibrils seeded by patient-extracted fibrils reveal new polymorphs and conserved fibril cores","volume":"28","author":"Cao","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105705","article-title":"A new polymorphism of human amylin fibrils with similar protofilaments and a conserved core","volume":"25","author":"Li","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.bpc.2026.107642_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169405","article-title":"Cryo-EM exposes diverse polymorphism in IAPP mutants to guide the rational design of peptide-based therapeutics","volume":"437","author":"Ooi","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0310","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1110\/ps.041051205","article-title":"Contribution of the intrinsic disulfide to the assembly mechanism of islet amyloid","volume":"14","author":"Koo","year":"2005","journal-title":"Protein Sci."},{"key":"10.1016\/j.bpc.2026.107642_bb0315","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1021\/acs.biochem.8b00017","article-title":"Analysis of the role of the conserved disulfide in amyloid formation by human islet amyloid polypeptide in homogeneous and heterogeneous environments","volume":"57","author":"Ridgway","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpc.2026.107642_bb0320","doi-asserted-by":"crossref","first-page":"12749","DOI":"10.1021\/bi030029q","article-title":"Self-assembly of Abeta(1-42) into globular neurotoxins","volume":"42","author":"Chromy","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpc.2026.107642_bb0325","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev-biochem-072909-095555","article-title":"Endoplasmic reticulum stress and type 2 diabetes","volume":"81","author":"Back","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bpc.2026.107642_bb0330","doi-asserted-by":"crossref","first-page":"23605","DOI":"10.1038\/s41598-025-05818-z","article-title":"Oxidative stress markers and inflammation in type 1 and 2 diabetes are affected by BMI, treatment type, and complications","volume":"15","author":"Cecerska-Heryc","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2026.107642_bb0335","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.19192","article-title":"The role of endoplasmic reticulum stress in type 2 diabetes mellitus mechanisms and impact on islet function","volume":"13","author":"He","year":"2025","journal-title":"PeerJ"},{"key":"10.1016\/j.bpc.2026.107642_bb0340","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.3390\/cimb45080420","article-title":"Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications","volume":"45","author":"Caturano","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0345","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/abbs\/gmu048","article-title":"New insights into the roles of CHOP-induced apoptosis in ER stress","volume":"46","author":"Li","year":"2014","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.bpc.2026.107642_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169048","article-title":"Off-pathway oligomers of \u03b1-synuclein and a\u03b2 inhibit secondary nucleation of \u03b1-synuclein amyloid fibrils","volume":"437","author":"Sch\u00fctzmann","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0355","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.289.5483.1317","article-title":"Nucleated conformational conversion and the replication of conformational information by a prion determinant","volume":"289","author":"Serio","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bpc.2026.107642_bb0360","doi-asserted-by":"crossref","first-page":"12666","DOI":"10.1074\/jbc.M109229200","article-title":"Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. evidence for an off-pathway oligomer at acidic pH","volume":"277","author":"Souillac","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2026.107642_bb0365","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jmb.2005.06.040","article-title":"Competing pathways determine fibril morphology in the self-assembly of beta2-microglobulin into amyloid","volume":"351","author":"Gosal","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2026.107642_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018171","article-title":"Spatial extent of charge repulsion regulates assembly pathways for lysozyme amyloid fibrils","volume":"6","author":"Hill","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2026.107642_bb0375","doi-asserted-by":"crossref","DOI":"10.1063\/1.4811343","article-title":"Structural fingerprints and their evolution during oligomeric vs. oligomer-free amyloid fibril growth","volume":"139","author":"Foley","year":"2013","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bpc.2026.107642_bb0380","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/bm501521r","article-title":"Stable, metastable, and kinetically trapped amyloid aggregate phases","volume":"16","author":"Miti","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bpc.2026.107642_bb0385","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1073\/pnas.0507471103","article-title":"Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis","volume":"103","author":"Yan","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bpc.2026.107642_bb0390","doi-asserted-by":"crossref","first-page":"10378","DOI":"10.1002\/anie.201302840","article-title":"Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Abeta40","volume":"52","author":"Yan","year":"2013","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.bpc.2026.107642_bb0395","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jbiotec.2014.06.006","article-title":"Engineered aggregation inhibitor fusion for production of highly amyloidogenic human islet amyloid polypeptide","volume":"191","author":"Mirecka","year":"2014","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bpc.2026.107642_bb0400","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1038\/s41467-022-30042-y","article-title":"Structural basis for the inhibition of IAPP fibril formation by the co-chaperonin prefoldin","volume":"13","author":"T\u00f6rner","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030146222600075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030146222600075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:02:08Z","timestamp":1783166528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030146222600075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":80,"alternative-id":["S030146222600075X"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2026.107642","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An islet amyloid polypeptide oligomer model inhibits fibril formation","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2026.107642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107642"}}